Back to Search
Start Over
XLT study results: BAK may not be the primary culprit in ocular adverse events with prostaglandin treatment: findings suggest factors other than exposure to the preservative contribute to side effects
- Source :
- Ophthalmology Times. January 15, 2009, Vol. 34 Issue 2, p29, 3 p.
- Publication Year :
- 2009
-
Abstract
- Atlanta -- Analyses of safety data from the Xalatan/Lumigan/Travatan (XLT) study, a 12-week, multicenter, double-masked, randomized clinical trial, provide no evidence that a direct, dose-response relationship exists between the occurrence [...]
- Subjects :
- Eye diseases -- Risk factors -- Research -- Complications and side effects
Prostaglandins -- Physiological aspects -- Health aspects -- Dosage and administration -- Complications and side effects -- Research
Chlorides -- Dosage and administration -- Complications and side effects -- Health aspects -- Physiological aspects -- Research
Dichloropropane -- Dosage and administration -- Complications and side effects -- Health aspects -- Physiological aspects -- Research
Health
Complications and side effects
Physiological aspects
Research
Risk factors
Dosage and administration
Health aspects
Subjects
Details
- Language :
- English
- ISSN :
- 0193032X
- Volume :
- 34
- Issue :
- 2
- Database :
- Gale General OneFile
- Journal :
- Ophthalmology Times
- Publication Type :
- Periodical
- Accession number :
- edsgcl.194810123